文献速递炎症性肠病消化道肿瘤与早癌

嗜黏蛋白阿克曼菌膜蛋白或巴氏灭活菌通过调节CD8+ T细胞减轻小鼠结肠炎相关肿瘤发生

A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice.
PubMed 文献 · Gut · 2020-03-13

该研究在小鼠中采用DSS诱导结肠炎后给予AOM建立结肠炎相关结直肠癌(CAC)模型,并给予巴氏灭活嗜黏蛋白阿克曼菌(A. muciniphila)或其外膜蛋白Amuc_1100干预。结果显示A. muciniphila在IBD和CAC患者及结肠炎/CAC小鼠中显著减少,而灭活菌或Amuc_1100可改善结肠炎并通过调节CD8+细胞毒性T淋巴细胞(CTLs)减轻肿瘤发生。

要点

  • A. muciniphila在IBD和CAC患者及模型小鼠中显著减少。
  • 巴氏灭活A. muciniphila或Amuc_1100可改善小鼠结肠炎。
  • 灭活菌或Amuc_1100通过扩增和激活CTLs减轻CAC肿瘤发生。

核心结论

  • 巴氏灭活A. muciniphila或Amuc_1100可通过调节CTLs减轻小鼠结肠炎和CAC。

研究设计与样本

  • 小鼠经DSS诱导结肠炎后给予AOM建立CAC模型,并给予巴氏灭活A. muciniphila或Amuc_1100干预。
  • 收集小鼠及IBD或CRC患者粪便进行16S rRNA测序。
  • 在急性结肠炎和CAC模型中研究A. muciniphila或Amuc_1100对免疫应答的影响。

主要发现

  • A. muciniphila在IBD患者及结肠炎或CAC小鼠中显著减少。
  • A. muciniphila或Amuc_1100改善结肠炎,减少结肠浸润巨噬细胞和CD8+ CTLs。
  • 治疗降低结肠炎小鼠脾和肠系膜淋巴结(MLN)中CD16/32+巨噬细胞。
  • Amuc_1100升高脾中PD-1+ CTLs。
  • A. muciniphila和Amuc_1100通过扩增结肠和MLN中CTLs减轻肿瘤发生,并激活MLN中CTLs(TNF-α诱导和PD-1下调)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Gut microbiota have been linked to inflammatory bowel disease (IBD) and colorectal cancer (CRC). Akkermansia muciniphila (A. muciniphila) is a gram-negative anaerobic bacterium that is selectively decreased in the faecal microbiota of patients with IBD, but its causative role and molecular mechanism in blunting colitis-associated colorectal cancer (CAC) remain inconclusive. This study investigates how A. muciniphila engages the immune response in CAC. DESIGN: Mice were given dextran sulfate sodium to induce colitis, followed by azoxymethane to establish CAC with or without pasteurised A. muciniphila or a specific outer membrane protein (Amuc_1100) treatment. Faeces from mice and patients with IBD or CRC were collected for 16S rRNA sequencing. The effects of A. muciniphila or Amuc_1100 on the immune response in acute colitis and CAC were investigated. RESULTS: A. muciniphila was significantly reduced in patients with IBD and mice with colitis or CAC. A. muciniphila or Amuc_1100 could improve colitis, with a reduction in infiltrating macrophages and CD8+ cytotoxic T lymphocytes (CTLs) in the colon. Their treatment also decreased CD16/32+ macrophages in the spleen and mesenteric lymph nodes (MLN) of colitis mice. Amuc_1100 elevated PD-1+ CTLs in the spleen. Moreover, A. muciniphila and Amuc_1100 blunted tumourigenesis by expanding CTLs in the colon and MLN. Remarkably, they activated CTLs in the MLN, as indicated by TNF-α induction and PD-1downregulation. Amuc_1100 could stimulate and activate CTLs from splenocytes in CT26 cell conditioned medium. CONCLUSIONS: These data indicate that pasteurised A. muciniphila or Amuc_1100 can blunt colitis and CAC through the modulation of CTLs.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Wang L, Tang L, Feng Y, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice. Gut. 2020. PMID: 32169907. doi:10.1136/gutjnl-2019-320105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。